Li Xiang, Tang Xiaonan, Wang Yufei, Chai Changwei, Zhao Zhehui, Zhang Haijing, Peng Ying, Wu Lianqiu
Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Front Pharmacol. 2021 Jul 9;12:655101. doi: 10.3389/fphar.2021.655101. eCollection 2021.
Rheumatoid arthritis (RA) is a chronic, systemic autoimmune disease that affects 1% of the population. CS-semi5 is a semisynthetic chondroitin sulfate. In this study, CS-semi5 was shown to have positive effects on a model of collagen-induced arthritis (CIA). CS-semi5 treatment had obvious effects on weight loss and paw swelling in CIA mice. Post-treatment analysis revealed that CS-semi5 alleviated three main pathologies (i.e., synovial inflammation, cartilage erosion and bone loss) in a dose-dependent manner. Further study showed that CS-semi5 could effectively reduce TNF-α and IL-1β production in activated macrophages the NF-κB pathway. CS-semi5 also blocked RANKL-trigged osteoclast differentiation from macrophages. Therefore, CS-semi5 may effectively ameliorate synovial inflammation, cartilage erosion and bone loss in RA through NF-κB deactivation.
类风湿性关节炎(RA)是一种影响1%人口的慢性全身性自身免疫性疾病。CS-semi5是一种半合成硫酸软骨素。在本研究中,CS-semi5对胶原诱导性关节炎(CIA)模型显示出积极作用。CS-semi5治疗对CIA小鼠的体重减轻和爪肿胀有明显影响。治疗后分析显示,CS-semi5以剂量依赖的方式减轻了三种主要病理变化(即滑膜炎症、软骨侵蚀和骨质流失)。进一步研究表明,CS-semi5可有效降低活化巨噬细胞中TNF-α和IL-1β的产生以及NF-κB信号通路的活性。CS-semi5还阻断了RANKL触发的巨噬细胞向破骨细胞的分化。因此,CS-semi5可能通过使NF-κB失活而有效改善RA中的滑膜炎症、软骨侵蚀和骨质流失。
Int Immunopharmacol. 2015-6
Front Physiol. 2023-6-28
Int J Mol Sci. 2020-11-28
Signal Transduct Target Ther. 2020-7-31
Autoimmun Rev. 2019-9-11
Future Med Chem. 2019-7-15
Molecules. 2019-4-12
Aging Clin Exp Res. 2019-4-13
Int Immunopharmacol. 2017-9